PRQR

アフターアワーズ： 1.70 -0.12 -6.59%

Proqr Therapeutics N V (PRQR)

Relative Volume:

ネットキャッシュフロー:

Proqr Therapeutics N V Stock (PRQR) Company Profile

Proqr Therapeutics N V

PRQR's Discussions on Twitter

Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2023-03-30	アップグレード	JMP Securities	Mkt Perform → Mkt Outperform
2022-12-22	アップグレード	Cantor Fitzgerald	Neutral → Overweight
2022-02-14	ダウングレード	Citigroup	Buy → Neutral
2022-02-11	ダウングレード	Raymond James	Strong Buy → Mkt Perform
2022-02-11	ダウングレード	Stifel	Buy → Hold
2022-02-01	開始されました	Raymond James	Strong Buy
2021-05-03	開始されました	Stifel	Buy
2021-03-25	繰り返されました	Citigroup	Buy
2020-11-03	再開されました	Cantor Fitzgerald	Overweight
2019-03-12	繰り返されました	Chardan Capital Markets	Buy
2018-12-19	開始されました	RBC Capital Mkts	Outperform
2018-11-15	開始されました	Citigroup	Buy
2018-09-19	開始されました	Evercore ISI	Outperform
2017-09-26	繰り返されました	JMP Securities	Mkt Outperform
2016-06-20	開始されました	Chardan Capital Markets	Neutral
2014-10-15	開始されました	Deutsche Bank	Buy
2014-10-13	開始されました	H.C. Wainwright	Buy

Proqr Therapeutics N V (PRQR) 最新ニュース

Proqr Therapeutics N V (PRQR) 財務データ

Proqr Therapeutics N V (PRQR)

Proqr Therapeutics N V Stock (PRQR) Company Profile

Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades

Proqr Therapeutics N V (PRQR) 最新ニュース

ProQR Therapeutics' SWOT analysis: RNA editing firm's stock faces pivotal phase - Investing.com UK

ProQR Therapeutics (NASDAQ:PRQR) Shares Pass Below Two Hundred Day Moving Average of $1.95 - MarketBeat

ProQR Therapeutics N.V (PRQR) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Market Momentum: ProQR Therapeutics N.V (PRQR) Registers a 7.14 Increase, Closing at 1.80 - The Dwinnex

ProQR Therapeutics (NASDAQ:PRQR) Shares Cross Below Two Hundred Day Moving Average of $1.96 - MarketBeat

ProQR Therapeutics (NASDAQ:PRQR) Stock Passes Below Two Hundred Day Moving Average of $1.96 - Defense World

ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference - GlobeNewswire

ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference - StockTitan

ProQR Therapeutics (NASDAQ:PRQR) Share Price Passes Above 50-Day Moving Average of $1.90 - MarketBeat

ProQR Therapeutics (NASDAQ:PRQR) Stock Price Crosses Above 50-Day Moving Average of $1.90 - Defense World

A look into ProQR Therapeutics N.V (PRQR)’s deeper side - SETE News

What technical indicators reveal about PRQR stock - US Post News

ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit - Yahoo Finance UK

ProQR Therapeutics NV (FRA:0PQ) Financial Strength : 3 (As of Jun. 2024) - GuruFocus.com

Reviewing ProQR Therapeutics (NASDAQ:PRQR) and OptiNose (NASDAQ:OPTN) - Defense World

ProQR Therapeutics NV (FRA:0PQ) Enterprise Value : €86.81 Mil (As of Aug. 17, 2024) - GuruFocus.com

Comparing Moleculin Biotech (NASDAQ:MBRX) & ProQR Therapeutics (NASDAQ:PRQR) - Defense World

ProQR: Q2 Earnings Snapshot - San Antonio Express-News

ProQR: Q2 Earnings Snapshot - San Francisco Chronicle

ProQR Therapeutics N.V. Financial Performance Review - TipRanks

ProQR Announces Second Quarter 2024 Operating and Financial Results - GlobeNewswire

ProQR Announces Second Quarter 2024 Operating and Financial Results - Yahoo Finance

Virtu Financial LLC Has $59,000 Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Acadian Asset Management LLC Takes $56,000 Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

BNP Paribas Financial Markets Increases Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

ProQR Therapeutics (NASDAQ:PRQR) Share Price Passes Below Two Hundred Day Moving Average of $2.00 - Defense World

ProQR Therapeutics (NASDAQ:PRQR) Share Price Crosses Below Two Hundred Day Moving Average of $2.00 - MarketBeat

ProQR Therapeutics (NASDAQ:PRQR) Shares Pass Below Two Hundred Day Moving Average of $2.01 - Defense World

ProQR Therapeutics (NASDAQ:PRQR) Stock Passes Below Two Hundred Day Moving Average of $2.01 - MarketBeat

ProQR Therapeutics N.V. (NASDAQ:PRQR) Investors Are Less Pessimistic Than Expected - Simply Wall St

StockNews.com Upgrades ProQR Therapeutics (NASDAQ:PRQR) to Hold - MarketBeat

ProQR Therapeutics (NASDAQ:PRQR) Sees Significant Drop in Short Interest - MarketBeat

StockNews.com Upgrades ProQR Therapeutics (NASDAQ:PRQR) to “Hold” - Defense World

Individual investors account for 45% of ProQR Therapeutics N.V.'s (NASDAQ:PRQR) ownership, while institutions ... - Yahoo New Zealand News

ProQR (PRQR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Movies UK

RFG Advisory LLC Makes New $73,000 Investment in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

ProQR (PRQR) Rises on Expanding RNA-Editing Deal With Eli Lilly - Yahoo Canada Shine On

ProQR Announces Upcoming Investor Conferences in November and December - Quantisnow

Lilly and ProQR to Expand RNA Editing Collaboration - Quantisnow

Regenxbio (RGNX) Soars 6.4%: Is Further Upside Left in the Stock? - Zacks Investment Research

Institutions own 25% of ProQR Therapeutics N.V. (NASDAQ:PRQR) shares but retail investors control 46% of the ... - Yahoo Finance UK

Institutions own 25% of ProQR Therapeutics N.V. (NASDAQ:PRQR) shares but retail investors control 46% of the company - Yahoo Finance

ProQR Therapeutics (NASDAQ:PRQR) Lowered to Sell at StockNews.com - Defense World

StockNews.com Lowers ProQR Therapeutics (NASDAQ:PRQR) to Sell - MarketBeat

ProQR (PRQR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo New Zealand News

A stock that deserves closer examination: ProQR Therapeutics N.V (PRQR) – US Post News - US Post News

ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit - Markets Insider

ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit - EIN News

PRQRProQR Therapeutics N.V. Ordinary Shares Latest Stock News & Market Updates - StockTitan

Xilio Therapeutics Appoints Aoife Brennan and James Shannon to its Board of Directors - citybiz

Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors - ForexTV.com

Proqr Therapeutics N V (PRQR) 財務データ

収益

当期純利益

現金流量

EPS

PRQRに似た銘柄